Literature DB >> 20216987

A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care.

Giampiero Mazzaglia1, Alessandro Filippi, Marianna Alacqua, Warren Cowell, Annabelle Shakespeare, Lorenzo G Mantovani, Cosetta Bianchi, Claudio Cricelli.   

Abstract

The aims of this study were to investigate trends in the incidence of diagnosed atrial fibrillation (AF), and to identify factors associated with the prescription of antithrombotics (ATs) and to identify the persistence of patients with oral anticoagulant (OAC) treatment in primary care. Data were obtained from 400 Italian primary care physicians providing information to the Health Search/Thales Database from 2001 to 2004. The age-standardised incidence of AF was: 3.9-3.0 cases, and 3.6-3.0 cases per 1,000 person-years in males and females, respectively. During the study period, 2,016 (37.2%) patients had no prescription, 1,663 (30.7%) were prescribed an antiplatelet (AP) agent, 1,440 (26.6%) were prescribed an OAC and 301 (5.5%) had both prescriptions. The date of diagnosis (p = 0.0001) affected the likelihood of receiving an OAC. AP, but not OAC, use significantly increased with a worsening stroke risk profile using the CHADS2 risk score. Older age increased the probability (p < 0.0001) of receiving an AP, but not an OAC. Approximately 42% and 24% of patients persisted with OAC treatment at one and two years, respectively, the remainder interrupted or discontinued their treatment. Underuse and discontinuation of OAC treatment is common in incident AF patients. Risk stratification only partially influences AT management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20216987     DOI: 10.1160/TH09-08-0525

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Prevalence of oral anticoagulant use among people with and without Alzheimer's disease.

Authors:  Barkat Ali Babar; Mai Vu; Marjaana Koponen; Heidi Taipale; Antti Tanskanen; Raimo Kettunen; Miia Tiihonen; Sirpa Hartikainen; Anna-Maija Tolppanen
Journal:  BMC Geriatr       Date:  2022-05-28       Impact factor: 4.070

2.  Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use.

Authors:  Thomas Wilke; Antje Groth; Matthias Pfannkuche; Oliver Harks; Andreas Fuchs; Ulf Maywald; Bernd Krabbe
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

3.  Warfarin Use and Mortality, Stroke, and Bleeding Outcomes in a Cohort of Elderly Patients with non-Valvular Atrial Fibrillation.

Authors:  Bradshaw Pamela J; Hung Joseph; Knuiman Matthew; Briffa Thomas G; Nedkoff Lee; Katzenellebogen Judith M; Rankin Jamie M; Sanfilippo Frank M
Journal:  J Atr Fibrillation       Date:  2019-06-30

Review 4.  Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.

Authors:  Miney Paquette; Lawrence Mbuagbaw; Alfonso Iorio; Robby Nieuwlaat
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-05-23

5.  Diagnosis and management of atrial fibrillation by primary care physicians in Italy : a retrospective, observational analysis.

Authors:  Gaetano Piccinocchi; Matteo Laringe; Bruno Guillaro; Giovanni Arpino; Roberto Piccinocchi; Gerardo Nigro; Paolo Calabrò
Journal:  Clin Drug Investig       Date:  2012-11       Impact factor: 2.859

6.  Supporting Treatment decision making to Optimise the Prevention of STROKE in Atrial Fibrillation: the STOP STROKE in AF study. Protocol for a cluster randomised controlled trial.

Authors:  Melina Gattellari; John M Worthington; Dominic Y Leung; Nicholas Zwar
Journal:  Implement Sci       Date:  2012-07-06       Impact factor: 7.327

7.  Antithrombotic prophylaxis of atrial fibrillation in an Italian real-world setting: a retrospective study.

Authors:  Giuliano Ermini; Valentina Perrone; Chiara Veronesi; Luca Degli Esposti; Giuseppe Di Pasquale
Journal:  Vasc Health Risk Manag       Date:  2017-07-05

Review 8.  Atrial Fibrillation in Older People: Concepts and Controversies.

Authors:  Zafraan Zathar; Anne Karunatilleke; Ameenathul M Fawzy; Gregory Y H Lip
Journal:  Front Med (Lausanne)       Date:  2019-08-08

9.  Warfarin and atrial fibrillation: from ideal to real the warfarin affaire.

Authors:  Mauro Molteni; Claudio Cimminiello
Journal:  Thromb J       Date:  2014-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.